23 stories found
The board of directors at Aurora Cannabis has officially advised shareholders to reject a hostile acquisition proposal from rival Curaleaf, deeming the offer financially inadequate. The recommendation underscores ongoing resistance to the competitor’s expansion efforts in the Canadian market.
Tilray, Canopy Growth, and Aurora Cannabis stocks saw gains of 6%, 3%, and 4% respectively, even as Tilray remains down 47% year-to-date, highlighting volatility in the cannabis sector.
Curaleaf is reportedly looking to acquire Aurora Cannabis for $272 million, raising speculation that Canopy Growth could be the next target for a marijuana takeover.
Curaleaf has announced a takeover bid for Aurora Cannabis, leading to an alert for ACB stock investors. The proposed acquisition could significantly impact the cannabis industry landscape.
An analysis suggests that Aurora Cannabis appears cheaper than its international growth trajectory would indicate. This quarterly update report delves into the company's financial standing and global expansion.
Aurora Cannabis and Major Drilling Group International have both released their Q4 earnings reports, with highlights from their respective earnings calls now available. Aurora Cannabis specifically reported its Q4 results.
Canadian cannabis company Aurora Cannabis (ACB) is reportedly exploring international markets as its domestic market faces significant challenges.
An analysis explores the potential for Aurora Cannabis stock to increase tenfold during an anticipated 'pot boom' in the market.
Two major cannabis producers, Curaleaf and Aurora, are publicly clashing over business practices and market positioning amid ongoing industry consolidation.
Shareholders of Aurora Cannabis are being urged to await further developments regarding a potential bid from Curaleaf.
Several significant deals were announced this week, involving companies such as Workday, Diversified Energy, and Aurora Cannabis, indicating notable activity across different market sectors.
The transcript for Aurora Cannabis's first-quarter 2027 earnings call has been released, providing details on the company's financial performance and outlook.
Highlights from Aurora Cannabis's Q1 earnings call have been released, providing a summary of the company's financial results and business developments for its first fiscal quarter.
Several prominent companies, including Oracle, Adobe, FuelCell Energy, Aurora Cannabis, and Chewy, are scheduled to release their earnings reports in the coming week.
Aurora Cannabis has completed the acquisition of Safari Flower Company for C$26.5 million.
Alliance Global has maintained a neutral rating on Canopy Growth Corporation (CGC), while Canaccord has expressed a bullish outlook on Aurora Cannabis Inc. (ACB).
Aurora Cannabis has issued a response to a hostile takeover bid from Curaleaf, indicating a developing corporate dispute in the cannabis industry.
Curaleaf has officially launched a hostile takeover bid for Aurora Cannabis, offering $4 per share. This move signals a significant development in the cannabis industry, as Curaleaf seeks to acquire its competitor.
The potential acquisition of Aurora Cannabis by Curaleaf is being evaluated, with analysts questioning whether such a move would be strategically beneficial for Curaleaf's market position and growth.
Curaleaf plans to take its takeover offer directly to shareholders in a bid to acquire Edmonton-based Aurora Cannabis. This move has caused Aurora Cannabis shares to jump, indicating market reaction to the potential acquisition.
Aurora Cannabis's latest quarterly update reveals that 55% of its revenue is now generated outside of Canada, primarily driven by a significant surge in medical cannabis sales.
Aurora Cannabis (ACB) is being evaluated as one of the leading stocks within the tobacco and cigarette industry.
Barclays has increased its price target for Altria Group (MO) to $63, while Canaccord initiated coverage for Aurora Cannabis (ACB) with a C$10 target, and Cronos Group (CRON) received a Buy rating and C$4.50 PT.